Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 97, Issue 2, 2001, Pages 208-212

  Isik, Ahmet Zeki ^a   Vicdan, Kubilay ^b  

^a Bayindir Medical Center   (Turkey)

^b 06540 a Ayranci ^*  (Turkey)

Author keywords

Albumin; IVF; Ovarian hyperstimulation syndrome; Prevention

Indexed keywords

ALBUMIN; CHORIONIC GONADOTROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; NAFARELIN ACETATE; PROGESTERONE; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HIGH RISK POPULATION; HUMAN; INFERTILITY; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE DONATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PATIENT MONITORING; PREGNANCY RATE; PRIORITY JOURNAL; TECHNIQUE;

EID: 0034931523     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(00)00539-X     Document Type: Article

References (28)

1. A new approach to the management of patients at risk of ovarian hyperstimulation in an in vitro fertilization programme
2. Management of overstimulated gonadotropin cycles with controlled drift period
3. Witholding gonadotropin administration is an effective alternative for prevention of ovarian hyperstimulation syndrome
4. Withholding gonadotropins ('coasting') to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles
5. Prospective randomized study of human chorionic gonadotropin versus intramuscular progesterone for luteal support in assisted reproduction
6. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety
7. Early timed follicular aspiration prevent severe ovarian hyperstimulation syndrome
8. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome
9. Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study
10. Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in vitro ferilization patients receiving intravenous albumin
11. Intravenous albumin prevents moderate-severe hyperstimulation in in vitro fertilization patients: a prospective, randomized and controlled study
12. Comparison between intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome
13. Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in vitro fertilization programme
14. Intravenous albumin combined with low dose human chorionic gonadotropin and late step-down administration of menotropins are effective in prevention of severe ovarian hyperstimulation syndrome in high-risk patients in an in vitro fertilization program
15. Severe OHSS. An epidemic of severe OHSS: a price we have to pay
16. Ovarian hyperstimulation syndrome: a current survey
17. Ovarian hyperstimulation syndrome
18. Pathology of the ovarian hyperstimulation syndrome
19. The pathogenesis of the ovarian hyperstimulation sydrome (OHSS): a possible role of ovarian renin
20. Vascular endothelial growth factor as a capillar permeability agent in ovarian hyperstimulation syndrome
21. Blood protein derivative viral safety: observations and analysis
22. The use of albumin in clinical practice
23. Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome
24. Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome
25. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins